Physician profile
Imran Baig
NPI 1659659969
$30,639.13
in general payments reported to CMS, 2019-2025
37 companies · $3,302 in 2025
The $3,302 reported for 2025 was more than what 77% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174 · 2020: $1,118 · 2021: $22K · 2022: $968 · 2023: $947 · 2024: $1,767 · 2025: $3,302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,493 · Travel and Lodging: $523.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,492.55 |
| Travel and Lodging | $522.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $23,825.96 | 2021-2025 | Corevalve Evolut R, Micra |
| Edwards Lifesciences Corporation | $1,767.35 | 2020-2025 | Sapien 3 Ultra Resilia, Pascal |
| Novartis Pharmaceuticals Corporation | $686.28 | 2022-2025 | |
| Abbott Laboratories | $464.52 | 2021-2025 | Mitraclip, Navitor |
| Cleerly, INC. | $317.37 | 2024-2025 | Cleerly Labs, Cleerly Ischemia |
| Amgen INC. | $273.08 | 2022-2025 | Repatha, Repatha |
| Abiomed | $269.19 | 2025 | |
| Philips North America LLC | $258.06 | 2022-2024 | (9520) Igt Devices Undivided |
| Heartflow, INC. | $219.43 | 2024-2025 | |
| Boston Scientific Corporation | $194.76 | 2022-2024 | Lux-Dx Insertable Cardiac Monitor, Watchman Access System |
| Astrazeneca Pharmaceuticals Lp | $193.20 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $190.49 | 2022-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $188.62 | 2023-2025 | Camzyos, Eliquis |
| Arineta, INC | $176.89 | 2024 | Spotlight |
| Penumbra, INC. | $163.96 | 2025 | Penumbra System |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $160.03 | 2022-2025 | Verquvo, Capvaxive |
| Terumo Medical Corporation | $149.89 | 2025 | Angio-Seal, Glidesheath Slender |
| Endologix LLC | $148.66 | 2024 | Endocross Device, Torus Stent Graft System |
| Angiodynamics, INC. | $146.53 | 2023-2025 | Alphavac, Auryon Laser System 100-120 Vac |
| Medtronic Vascular, INC. | $140.24 | 2019 | |
| Cardiovascular Systems INC. | $126.00 | 2023 | Diamondback Peripheral |
| Shockwave Medical, INC | $119.14 | 2025 | |
| Inspire Medical Systems, INC. | $61.16 | 2025 | Inspire |
| Silk Road Medical, INC. | $49.95 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Pfizer INC. | $47.59 | 2024 | |
| Esperion Therapeutics, INC. | $46.19 | 2023 | Nexletol |
| Stryker Corporation | $46.00 | 2025 | Flowtriever |
| Reflow Medical INC | $32.48 | 2024 | |
| Ucb, INC. | $25.72 | 2024 | Bimzelx |
| Cashflow Solutions, LLC | $24.28 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Vital Connect, INC | $22.07 | 2025 | Vitalpatch Rtm |
| Janssen Pharmaceuticals, INC | $20.10 | 2024 | Xarelto |
| Cordis US Corp. | $19.97 | 2025 | Selution Slr Ptca |
| Scpharmaceuticals INC. | $17.98 | 2023 | |
| Irhythm Technologies, INC. | $16.74 | 2024 | Zio Xt Patch, Zio Monitor |
| Novo Nordisk INC | $16.02 | 2024 | Ozempic |
| Biotronik INC. | $13.23 | 2024 | Biomonitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Imran Baig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.